Parlar S

References (10)

Title : Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid-beta aggregation inhibition studies of substituted 4,4'-diimine\/4,4'-diazobiphenyl derivatives - Fidan_2022_Arch.Pharm.(Weinheim)__e2200152
Author(s) : Fidan GS , Parlar S , Tarikogullari AH , Alptuzun V , Alpan AS
Ref : Arch Pharm (Weinheim) , :e2200152 , 2022
Abstract :
PubMedSearch : Fidan_2022_Arch.Pharm.(Weinheim)__e2200152
PubMedID: 35976708

Title : N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity - Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
Author(s) : Parlar S , Sayar G , Tarikogullari AH , Karadagli SS , Alan E , Sevin G , Erciyas E , Holzgrabe U , Alptuzun V
Ref : Arch Pharm (Weinheim) , :e2200519 , 2022
Abstract :
PubMedSearch : Parlar_2022_Arch.Pharm.(Weinheim)__e2200519
PubMedID: 36461719

Title : Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones - Parlar_2019_Bioorg.Chem_87_888
Author(s) : Parlar S , Sayar G , Tarikogullari AH , Karadagli SS , Alptuzun V , Erciyas E , Holzgrabe U
Ref : Bioorg Chem , 87 :888 , 2019
Abstract :
PubMedSearch : Parlar_2019_Bioorg.Chem_87_888
PubMedID: 30538051

Title : Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors - Uysal_2018_Arch.Pharm.(Weinheim)_351_e1700273
Author(s) : Uysal S , Parlar S , Tarikogullari AH , Aydin Kose F , Alptuzun V , Soyer Z
Ref : Arch Pharm (Weinheim) , 351 :e1700273 , 2018
Abstract :
PubMedSearch : Uysal_2018_Arch.Pharm.(Weinheim)_351_e1700273
PubMedID: 29527733

Title : Multifunctional cholinesterase inhibitors for Alzheimer's disease: Synthesis, biological evaluations, and docking studies of o\/p-propoxyphenylsubstituted-1H-benzimidazole derivatives - Sarikaya_2018_Arch.Pharm.(Weinheim)__
Author(s) : Sarikaya G , Coban G , Parlar S , Tarikogullari AH , Armagan G , Erdogan MA , Alptuzun V , Alpan AS
Ref : Arch Pharm (Weinheim) , : , 2018
Abstract :
PubMedSearch : Sarikaya_2018_Arch.Pharm.(Weinheim)__
PubMedID: 29984517

Title : Mannich-Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study - Alpan_2017_Arch.Pharm.(Weinheim)_350_
Author(s) : Alpan AS , Sarikaya G , Coban G , Parlar S , Armagan G , Alptuzun V
Ref : Arch Pharm (Weinheim) , 350 : , 2017
Abstract :
PubMedSearch : Alpan_2017_Arch.Pharm.(Weinheim)_350_
PubMedID: 28379621

Title : Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors - Soyer_2017_J.Enzyme.Inhib.Med.Chem_32_13
Author(s) : Soyer Z , Uysal S , Parlar S , Tarikogullari Dogan AH , Alptuzun V
Ref : J Enzyme Inhib Med Chem , 32 :13 , 2017
Abstract :
PubMedSearch : Soyer_2017_J.Enzyme.Inhib.Med.Chem_32_13
PubMedID: 27766908

Title : Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors - Parlar_2016_Chem.Pharm.Bull.(Tokyo)_64_1281
Author(s) : Parlar S , Bayraktar G , Tarikogullari AH , Alptuzun V , Erciyas E
Ref : Chem Pharm Bull (Tokyo) , 64 :1281 , 2016
Abstract :
PubMedSearch : Parlar_2016_Chem.Pharm.Bull.(Tokyo)_64_1281
PubMedID: 27581632

Title : Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors - Alpan_2013_Bioorg.Med.Chem_21_4928
Author(s) : Alpan AS , Parlar S , Carlino L , Tarikogullari AH , Alptuzun V , Gunes HS
Ref : Bioorganic & Medicinal Chemistry , 21 :4928 , 2013
Abstract :
PubMedSearch : Alpan_2013_Bioorg.Med.Chem_21_4928
PubMedID: 23891231

Title : 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BCHE, and amyloid-beta aggregation crossing the blood-brain barrier - Prinz_2013_Eur.J.Pharm.Sci_49_603
Author(s) : Prinz M , Parlar S , Bayraktar G , Alptuzun V , Erciyas E , Fallarero A , Karlsson D , Vuorela P , Burek M , Forster C , Turunc E , Armagan G , Yalcin A , Schiller C , Leuner K , Krug M , Sotriffer CA , Holzgrabe U
Ref : Eur J Pharm Sci , 49 :603 , 2013
Abstract :
PubMedSearch : Prinz_2013_Eur.J.Pharm.Sci_49_603
PubMedID: 23643737